Association Between Immune-Related Adverse Events and Clinical Efficacy in Patients with Melanoma Treated With Nivolumab: A Multicenter Retrospective Study
Naoto Okada(Yamaguchi University Hospital), Keisuke Ishizawa(Tokushima University Hospital), Ryo Utsunomiya(Ehime University), Mitsuhiro Goda(Okayama University), Yoshiaki Kubo(Tokushima University), Koji Sayama(Ehime University), Yoshihiro Matsudate(Tokushima University), Masaki Imanishi(Tokushima University Hospital), Masayuki Chuma(Nihon University), Akihiro Tanaka(Izumi City General Hospital), Kenshi Takechi(Matsuyama University), Noriaki Hidaka(Hanwa Memorial Hospital), Yoshito Zamami(Tokushima University Hospital)
Cited by 99
Related Papers
Factors Associated With Immune Checkpoint Inhibitor–Related Myocarditis
|JAMA Oncology|2019|134
Royal Jelly Ameliorates Insulin Resistance in Fructose-Drinking Rats
|Biological and Pharmaceutical Bulletin|2008|88
Trends in Polypharmacy in Japan: A Nationwide Retrospective Study
|Journal of the American Geriatrics Society|2018|81
Antitumor effect of novel anti‐podoplanin antibody NZ‐12 against malignant pleural mesothelioma in an orthotopic xenograft model
|Cancer Science|2016|62
The uremic toxin indoxyl sulfate interferes with iron metabolism by regulating hepcidin in chronic kidney disease
|Nephrology Dialysis Transplantation|2017|60